Zobrazeno 1 - 3
of 3
pro vyhledávání: '"I. A. Valouev"'
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 1, Pp 208-215 (2024)
Introduction. Adalimumab, a fully humanized monoclonal antibody, is a tumor necrosis factor (TNFα) inactivator that is used against a number of autoimmune diseases such as rheumatoid arthritis and other most common inflammatory arthropathies (ankylo
Externí odkaz:
https://doaj.org/article/61c7f9e522ba49819af0b0a58b6b54e9
Autor:
Natalia V. Kochneva-Pervukhova, V. N. Urakov, Michael D. Ter-Avanesyan, Vladimir N. Smirnov, I. A. Valouev
Publikováno v:
Molecular Microbiology. 53:687-696
The translation termination factor eRF1 recognizes stop codons at the A site of the ribosome and induces peptidyl-tRNA hydrolysis at the peptidyl transferase centre. Recent data show that, besides translation, yeast eRF1 is also involved in cell cycl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3face89768c11a10b9f61173f8cef7e5
https://doi.org/10.1111/j.1365-2958.2004.04157.x
https://doi.org/10.1111/j.1365-2958.2004.04157.x
Publikováno v:
Molecular microbiology. 53(2)
The translation termination factor eRF1 recognizes stop codons at the A site of the ribosome and induces peptidyl-tRNA hydrolysis at the peptidyl transferase centre. Recent data show that, besides translation, yeast eRF1 is also involved in cell cycl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ff80a05356febcb2663bd8b989ce623
https://pubmed.ncbi.nlm.nih.gov/15228544
https://pubmed.ncbi.nlm.nih.gov/15228544